Showing 1 - 3 results of 3 for search 'Wey, Y.S' Skip to content
VuFind
  • Feedback
  • 我的帳戶
  • 退出
  • 登錄
  • Theme
    • Bootstrap
    • Aunilo
  • 語言
    • English
    • 中文(繁體)
    • اللغة العربية
高級檢索
  • 作者
  • Wey, Y.S
Showing 1 - 3 results of 3 for search 'Wey, Y.S', 查詢時間: 0.02s Refine Results
1
The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy
由 Chaurasia, S.S, Lim, R.R, Parikh, B.H, Wey, Y.S, Tun, B.B, Wong, T.Y, Luu, C.D, Agrawal, R, Ghosh, A, Mortellaro, A, Rackoczy, E, Mohan, R.R, Barathi, V.A
出版 2020
獲取全文
Article
加到收藏夾
Saved in:
2
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
由 Regula, J.T, Lundh von Leithner, P, Foxton, R, Barathi, V.A, Cheung, C.M.G, Bo Tun, S.B, Wey, Y.S, Iwata, D, Dostalek, M, Moelleken, J, Stubenrauch, K.G, Nogoceke, E, Widmer, G, Strassburger, P, Koss, M.J, Klein, C, Shima, D.T, Hartmann, G
出版 2020
獲取全文
Article
加到收藏夾
Saved in:
3
Erratum to: Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases (EMBO Molecular Medicine, (2016), 8, 11, (1265-1288), 10.15252/emmm.201505889)
Erratum to: Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases (EMBO Molecular Medicine, (2016), 8, 11, (1265-1288), 10.15252/emmm....
由 Regula, J.T., Lundh von Leithner, P., Foxton, R., Barathi, V.A., Gemmy Cheung, C.M., Bo Tun, S.B., Wey, Y.S., Iwata, D., Dostalek, M., Moelleken, J., Stubenrauch, K.G., Nogoceke, E., Widmer, G., Strassburger, P., Koss, M.J., Klein, C., Shima, D.T., Hartmann, G.
出版 2020
獲取全文
Others Erratum
加到收藏夾
Saved in:
檢索工具: 得到RSS訂閱 — 推薦此搜索 —

檢索選項

  • 檢索歷史
  • 高級檢索

查找更多

  • 瀏覽目錄
  • 按字母順序瀏覽
  • Explore Channels
  • 課程儲備
  • 新項目

需要幫助?

  • 檢索技巧
  • 咨詢台
  • 常見問題
載入...